ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

STXS Stereotaxis Inc

2.34
0.02 (0.86%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Stereotaxis Inc AMEX:STXS AMEX Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.02 0.86% 2.34 2.4797 2.30 2.35 251,257 01:00:00

Stereotaxis to Report Second Quarter 2020 Financial Results on August 6, 2020

23/07/2020 9:05pm

GlobeNewswire Inc.


Stereotaxis (AMEX:STXS)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Stereotaxis Charts.

Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2020 second quarter on Thursday, August 6, 2020 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 10:00 a.m. Eastern Time that day to discuss the Company’s results and corporate developments.

What:Stereotaxis second quarter financial results conference call
  
When:Thursday, August 6, at 10:00 a.m. Eastern Time (7:00 a.m. PT)
  
Dial In Number:To access the live call, dial 888-394-8218 (US and Canada) or 786-789-4776 (International) and give the participant pass code 6170258.
  
Webcast: To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at http://ir.stereotaxis.com/
  
Call Replay:A phone replay of the call will be available for one week beginning approximately two hours following the end of the call through August 13, 2020. To request access for a replay of the conference call, please click here.
  

About Stereotaxis

Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The core components of Stereotaxis’ systems have received regulatory clearance in the United States, European Union, Japan, Canada, China, and elsewhere. For more information, please visit www.stereotaxis.com.

Company Contacts:David L. FischelChairman and Chief Executive Officer

Kimberly PeeryChief Financial Officer

314-678-6100investors@stereotaxis.com

1 Year Stereotaxis Chart

1 Year Stereotaxis Chart

1 Month Stereotaxis Chart

1 Month Stereotaxis Chart

Your Recent History

Delayed Upgrade Clock